What GreenCare Pharma does

GreenCare Pharma is a privately-held Brazilian pharmaceutical company that imports and distributes cannabinoid-based medications under its proprietary Hempflex brand to patients holding valid medical prescriptions. The company operates exclusively in the Brazilian market and facilitates the end-to-end workflow from physician prescription through ANVISA (Brazilian Health Regulatory Agency) authorization to product delivery, positioning itself as the "fastest-growing company in Brazil's cannabinoid-based medication segment" per its own corporate materials.

The company's core offering is the Hempflex product line of CBD and THC formulations manufactured according to international regulatory standards, imported into Brazil and sold via an e-commerce store, phone sales, WhatsApp, and direct customer support. It operates a B2B2C model targeting two primary segments: licensed physicians (recruited and educated through the Instituto GreenCare e-learning platform) and patients (guided through documentation, ANVISA filing, and importation logistics). Technology infrastructure is centered on a WordPress storefront, a dedicated physician portal, and the PATIENTCARE patient portal at patient.greencarepharma.com.br.

GreenCare monetizes through one-time cannabis medication sales and bundled patient support services that handle ANVISA bureaucratic procedures and delivery coordination. Pricing is not publicly disclosed and requires direct contact. The company's differentiation rests on three pillars: medical education via Instituto GreenCare, strategic global partnerships providing exclusive access to internationally recognized quality products, and full-service regulatory facilitation. Key data gaps include the absence of disclosed revenue, headcount, funding history, ownership structure, and management team information.

Name

GreenCare Pharma

Legal name

GreenCare

Website

https://greencare.store

Company type

Private

Founded year

2018

Operating status

Operating

Headcount range

11–50 employees

Short description

GreenCare Pharma is a privately-held Brazilian pharmaceutical company that imports and distributes Hempflex-branded cannabinoid-based medications (CBD and THC formulations) to patients with valid prescriptions, supporting physicians via its Instituto GreenCare e-learning platform and handling ANVISA regulatory facilitation.

Ownership category

akta.pro rank

Product category

Medical Cannabis Pharmaceuticals

NAICS

Medicinal and Botanical Manufacturing (325411), Drugs and Druggists' Sundries Merchant Wholesalers (42421), Pharmacies and Drug Retailers (456110)

SIC

Pharmaceutical Preparations (2834), Medicinal Chemicals & Botanical Products (2833), Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)

akta.pro primary industry

Cannabis Dispensary + Pharmacy/Clinical Model (Patient Services) (CRANAFAI)

akta.pro secondary industries

Medical Cannabis Delivery & Online Ordering (CRANAGAG), Dispensary-Owned Online Ordering & Delivery (Direct-to-Consumer) (CRANAGAE)

Keywords

• Medical cannabis products
• Cannabinoid medications
• Pharmaceutical importation
• Patient support services
• Medical education platform

Headquarters

HQ city

São Paulo

HQ country

Brazil

HQ region

Latin America

Markets served

GTM type

B2B and B2C

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

1. Cannabis Medication Sales: GreenCare imports and sells cannabis-based medications (Hempflex brand) to patients with valid medical prescriptions in Brazil. The company facilitates the entire process including ANVISA documentation, authorization handling, and product delivery.
2. Patient Support Services: The company assists patients throughout the purchase and importation process, handling bureaucratic procedures with ANVISA, providing medical information support, and managing product delivery logistics.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels5 records

Core offering

GreenCare imports and sells cannabis-based pharmaceutical products under the Hempflex brand to patients in Brazil who hold a valid medical prescription. The company manages the full process — prescription intake, ANVISA documentation and authorization, importation logistics, and home delivery — and supports prescribing physicians with scientific information, technical assistance, and continuing medical education through the Instituto GreenCare (IGC) e-learning platform.

Product overview

GreenCare Pharma is a Brazilian pharmaceutical company specializing in medical cannabis products. The company operates primarily through its Hempflex product line, which comprises cannabinoid-based medications (CBD and THC formulations) imported into Brazil and distributed to patients with valid medical prescriptions. GreenCare facilitates the entire import process, including ANVISA authorization handling and direct delivery to patients. The company also provides educational resources for physicians through the Instituto GreenCare (IGC) e-learning platform and maintains a compliance hotline for ethical reporting.

Differentiator

Problem solved

Functional benefit

Brands

• Hempflex: Product brand line for cannabinoid-based medications, manufactured according to global regulatory practices, offering legally compliant, safe, and effective products derived from cannabinoids.

Products and services

• Hempflex GreenCare's main product line of cannabinoid-based medicines, including CBD and THC formulations, manufactured according to international regulatory standards and imported into Brazil for patients with valid medical prescriptions.
• Instituto GreenCare (IGC) E-learning platform delivering continuing medical education on cannabinoid-based therapeutics to licensed healthcare professionals, who share knowledge and clinical experience with Hempflex products.
• PATIENTCARE Patient portal (patient.greencarepharma.com.br) where patients in Brazil submit required documentation, manage their accounts, and access ongoing support for their cannabis-based treatment under GreenCare.

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature1 record

Partnerships

One partnership is on record.

• Instituto GreenCare (IGC)coreStrategic or Co-development PartnerInstituto GreenCare is the company's proprietary e-learning platform for continuing medical education in cannabinoid-based therapeutics. Healthcare professionals share knowledge and experiences about cannabinoid products through this platform, serving as the company's primary educational and GTM mechanism for the physician segment.

Scale indicators1 record

Recent moves5 records

Expansion highlights3 records

Direct peers

• Sativaria Brasil: Brazilian medical cannabis company importing and distributing cannabinoid products to patients with prescriptions. Comparable in regulatory pathway focus, product importation, and patient services.
• Abrace Vida (formerly Abrace Esperança): Brazilian medical cannabis patient association that cultivates, manufactures, and distributes cannabis-based medications to patients with medical prescriptions. Directly comparable in B2B2C physician-and-patient model, ANVIA pathway navigation, and Brazilian market focus.
• OnixCann: Brazilian medical cannabis operator focused on patient access to imported cannabis-based medications under ANVIA. Direct competitor in the same regulatory pathway and physician-engagement model.
• Cannect: Brazilian medical cannabis operator supporting patients through the ANVIA authorization and importation process with a similar prescriber-enablement model. Overlaps directly with GreenCare on the service-stack and importation facilitation positioning.

Emerging players

• Zelira Therapeutics: Cannabinoid-based pharmaceutical company developing prescription products for therapeutic indications. Comparable in the pharmaceutical-grade cannabis medication positioning and clinical/regulatory focus.
• Khiron Life Sciences: Cannabis company with Latin American focus including physician education and patient services. Comparable in the B2B2C medical cannabis model targeted at Latin American physicians and patients.
• Clever Leaves: International medical cannabis cultivator and manufacturer with export capabilities into emerging regulated markets including Latin America. Comparable as a potential upstream supplier/partner for GreenCare's imported product line.

Broad incumbents

• Canopy Growth Corporation: Global cannabis producer with medical cannabis portfolios across multiple jurisdictions. Adjacent incumbent with potential to compete in Brazil through institutional partnerships and product breadth.
• Mantecorp Farmasa (cannabis line): Established Brazilian pharmaceutical company that has expanded into medical cannabis products. Comparable on the pharmaceutical-grade medications positioning, but with a broader pharma portfolio and distribution scale.
• Tilray Brands: Large international cannabis producer with established operations in Brazil and globally. Broad incumbent providing similar cannabis-based medications internationally, with significant scale advantages in cultivation and capital.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Key risks6 records

Key highlights6 records

Customer concentration

• Facebookfacebook.com/GreenCareStore
• LinkedInlinkedin.com/company/greencarestore
• Instagraminstagram.com/greencare_store

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about GreenCare Pharma